CLPT ClearPoint Neuro, Inc. Загрузка... : Бычьи и медвежьи мнения аналитиков
Загрузка графика...
Лучшие сигналы
Лента
16:56
23 июн
23 июн
Автор выражает симпатию к CLPT, но не заявляет о наличии текущей позиции или прогнозируемых.
Автор выражает симпатию к CLPT, но не заявляет о наличии текущей позиции или прогнозируемых торговых рекомендациях.
Низ.
20:05
18 июн
18 июн
Автор называет эти тикеры в рамках личного фокуса/списка отслеживания наряду с обновлением.
Автор называет эти тикеры в рамках личного фокуса/списка отслеживания наряду с обновлением портфеля; к какому-либо отдельному названию не прилагается явных формулировок о позициях или направленного тезиса.
Низ.
13:51
17 июн
17 июн
UniQure news revitalizes ClearPoint Neuro's platform.
Positive news regarding uniQure's study data revitalizes ClearPoint's platform, which was previously delegitimized by the FDA's handling of the AMT-130 study.
Сред.
14:23
24 окт
24 окт
Position closed to take massive profits
The position in CLPT was closed to take profits after a huge win, with further short-term upside above $30 seen as reliant purely on hype.
Сред.
09:54
05 окт
05 окт
Criticizes CLPT's high meme valuation multiples
Criticizes CLPT's high valuation multiples, arguing the brain surgery market lacks the exploding demand needed to justify comparisons to Nvidia.
Сред.
15:32
04 окт
04 окт
CLPT captures small slice of value chain
Compares CLPT's market position to Zeiss, noting it provides unique technology but captures a smaller portion of the value chain.
Сред.
19:48
03 окт
03 окт
Critical enabler for neurodegenerative disease therapies.
Author highlights the company's critical role in enabling and controlling therapies for major neurodegenerative diseases.
Сред.
18:03
03 окт
03 окт
Trims position for portfolio sizing after tripling.
Author trimmed position for portfolio sizing reasons after it nearly tripled, though remains bullish on its path to a $1B market cap.
Сред.
12:51
02 окт
02 окт
Indispensable MedTech partner with massive FCF potential.
Author remains long, arguing the stock is cheap given its indispensable role to 60 partners and potential approvals worth billions in free cash flow.
Выс.
08:48
25 сен
25 сен
Strongly invested citing huge platform potential
Author is strongly invested, citing huge potential as a platform for life-changing therapies and viewing it as a great long-term investment.
Сред.
06:16
25 сен
25 сен
Discloses large existing positions and recent additions
Author discloses large existing positions and recent additions across these names in a monthly portfolio update.
Сред.
10:01
15 авг
15 авг
Author holds large CLPT position
Author discloses the stock is among their biggest current positions.
Сред.
12:06
11 авг
11 авг
Speculates on potential revenue-boosting device partnership
Speculates that a potential device partnership and clinical success could significantly boost mid-term revenue and gross margins.
Сред.
14:21
14 июл
14 июл
Author lists largest current portfolio positions
Author discloses these names as their largest current portfolio positions, indicating ongoing bullish conviction and significant capital allocation.
Сред.
12:13
16 мая
16 мая
Growth play with strong future potential.
Author views the stock as a compelling growth play where current prices represent the ground floor for future potential, despite weak present fundamentals.
Сред.
16:47
06 мая
06 мая
Discloses CLPT as top portfolio holding
Author discloses CLPT as a top portfolio holding by weighting.
Сред.
15:24
14 мар
14 мар
Discloses recent portfolio purchases and additions
Author discloses recent portfolio purchases and additions across multiple names over the past two weeks.
Сред.
15:01
28 фев
28 фев
Immense moat and disruptive advantage in healthcare
Author is highly bullish on the company's immense value proposition, disruptive customer advantage, and strong competitive moat within the healthcare sector.
Сред.
15:09
27 фев
27 фев
Buying the dip for $1B market cap
Author is buying the post-call dip, projecting that the company will eventually reach a one billion dollar market capitalization.
Сред.
17:58
25 фев
25 фев
Discloses large long-term investment position.
Author discloses this ticker as one of their largest current positions and a long-term investment.
Сред.
09:23
26 окт
26 окт
Discloses long positions in medical technology names
Author discloses existing long positions in medical technology names focused on lasers, magnetic stimulation, and imaging.
Сред.
18:30
26 авг
26 авг
CLPT essential for guiding neurological therapies
Bullish on CLPT due to its essential role in guiding developing neurological therapies to their destinations in the brain.
Сред.
Об аналитическом покрытии CLPT
Buzzberg отслеживает CLPT (ClearPoint Neuro, Inc.) в 2 источниках. Бычьих сигналов: 3, медвежьих: 0, от 2 аналитиков. Сентимент преимущественно бычий (14%). Всего отслеживаются 22 торговые идеи. Последние спикеры: thematictrader, moodywriter13, @MoodyWriter13.